[Primary vasculitis of central nervous system]. 2021

Mathieu Zuber
Service de neurologie et neurovasculaire, Groupe hospitalier Paris Saint-Joseph, Paris, France - Université de Paris, France.

"Primary vasculitis of central nervous system.Primary vasculitis of central nervous system (PVCNS) is an uncommon condition and diagnosis with an acceptable degree of certainty remains a difficult challenge. Parietal inflammation of the cerebral vessels appears in the absence of systemic disease. Publication of large cohorts of well-explored patients in USA and France over the 2 past decades significantly increased the experience. Headache is the most frequent symptom, generally associated with stroke or encephalopathy. Brain imaging including MRI and vascular imaging (MRA/CT angiography + conventional angiography) is now the cornerstone of diagnosis and cerebral biopsy seldom performed. Favorable prognostic factors have been identified in PVCNS, i.e. distal vessel involvement, no/very few ischemic events and meningeal enhancements after gadolinium injection. When these are present, prednisone is usually the only treatment proposed. Otherwise, cyclophosphamide is added to prednisone for 4 to 6 months, and maintenance immunosuppressive therapy is prescribed. Mortality of PVCNS is now 5-10% at 5 years, thanks to modern and rational medical care."

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D020293 Vasculitis, Central Nervous System Inflammation of blood vessels within the central nervous system. Primary vasculitis is usually caused by autoimmune or idiopathic factors, while secondary vasculitis is caused by existing disease process. Clinical manifestations are highly variable but include HEADACHE; SEIZURES; behavioral alterations; INTRACRANIAL HEMORRHAGES; TRANSIENT ISCHEMIC ATTACK; and BRAIN INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, pp856-61) Angiitis, Central Nervous System,Central Nervous System Vasculitis,Cerebral Angiitis,Cerebral Vasculitis,Granulomatous Angiitis,Postzoster Arteritis,Primary CNS Vasculitis,Secondary CNS Vasculitis,CNS Vasculitis,Central Nervous System Angiitis,Granulomatous Arteritis,Primary Central Nervous System Vasculitis,Vasculitis, CNS, Secondary,Angiitis, Cerebral,Angiitis, Granulomatous,Arteritis, Granulomatous,Arteritis, Postzoster,CNS Vasculitis, Primary,CNS Vasculitis, Secondary,Vasculitis, CNS,Vasculitis, Cerebral,Vasculitis, Primary CNS,Vasculitis, Secondary CNS

Related Publications

Mathieu Zuber
December 2015, Zeitschrift fur Rheumatologie,
Mathieu Zuber
May 2021, Brain and nerve = Shinkei kenkyu no shinpo,
Mathieu Zuber
January 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
Mathieu Zuber
August 2012, Lancet (London, England),
Mathieu Zuber
July 2017, The Israel Medical Association journal : IMAJ,
Mathieu Zuber
January 2014, Clinical and experimental rheumatology,
Mathieu Zuber
November 2012, Journal of child neurology,
Mathieu Zuber
October 2016, Ugeskrift for laeger,
Mathieu Zuber
February 2011, Rheumatology (Oxford, England),
Copied contents to your clipboard!